STOK: Stoke Therapeutics Sotuvning sof marjinal rentabelligi

Ommaviy kompaniya Stoke (STOK) logotipi

Stoke Therapeutics (STOK) TANGO innovatsiyalari orqali bolalar epilepsiyasi davolashining orfan segmentini monopolizatsiya qilishni maqsad qilgan. GURU.Markets grafigidagi sof marja vaqtlar ketma-ketligi ushbu trayektoriyani tasdiqlaydi, bunda -862.10 joriy darajani ko'rsatadi. Biroq, geosiyosiy keskinliklar biomateriallarning transchegaraviy almashinuviga to'sqinlik qilmoqda, RNAga asoslangan dorilar esa klinik bosqichda qolmoqda va hali bevosita foyda keltirmayapti.

STOK: stoketherapeutics.com Sotuvning sof marjinal rentabelligi 04.07.2022 - 19.11.2026

Stoke (STOK) boʻyicha maʼlumotlarning jamlanma tahliliy kesimlari

- bozor qiymati va tahlilchilarning maqsadli prognozi:
- bozor kapitallashuvi haqida ma'lumot:
Kompaniyaning asosiy tahlili:Stoke Therapeutics
Stoke Therapeutics Inc yetakchi tovari

Stoke Therapeutics (STOK) kompaniyasida noyob gen funksiyalarini tiklash usullarini ishlab chiqishning o'ziga xos xususiyatlari biznesni tadqiqot va ishlanmalar (R&D) xarajatlarini boshqarish samaradorligiga bog'liq qiladi. Operatsion sof foyda marjasini tahlil qilish orqali investor har bir dollar daromadning foyda ulushini baholaydi, bu esa pul oqimining xarajatlar inflyatsiyasiga chidamliligini aniqlash va o'zgaruvchan bozor sharoitlarida aktivlarning qayta baholanishi xavfini baholash imkonini beradi.

Stoke Therapeutics (STOK) raqobatchilari

TEM: Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha marjinallik Qiagen QGEN|IONS (Isis Pharmaceuticals) - Sotuvning sof marjinal rentabelligi|Repligen Inc. - Sof foyda marjasi|Sotuvning sof marjinal rentabelligi RNA|CRSP - Sof marja|GeneDx - Sof foyda bo'yicha sotuv rentabelligi|Sof foyda normasi RARE|Beam Tx - Sotuvning sof marjinal rentabelligi|SRPT - Sotuvning sof marjinal rentabelligi|TWST (Twist Bio) - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof rentabelligi TXG|Sof foyda bo'yicha sotuv rentabelligi NTLA|BLFS: Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi WVE (Wave Life Sciences Corp)|Kompaniya sotuv marjasi Maze Therapeutics Corp|Sionna Therapeutics Inc - Sof foyda bo'yicha sotuv rentabelligi|PRME (primemedicine.com) - Sof foyda marjasi|TSHA - Sof marja|QURE (uniQure) - Sotuvning sof rentabelligi|MeiraGTx Corp (MGTX) - Sof marja|Regenxbio - Sof foyda normasi|Sof marja solidbio.com|Sof marja ocugen.com OCGN|Sotuvning sof marjinal rentabelligi PACB|Benitec - Sotuvning sof rentabelligi|Sof marja Design Therapeutics DSGN|Sotuvning sof marjinal rentabelligi Rocket Pharmaceuticals RCKT|Sof foyda marjasi 4D Molecular Corp|LXEO: Sof marja|KRRO (Korro Bio, Inc) - Sof foyda bo'yicha sotuv rentabelligi|Editas Medicine (EDIT) - Sotuvning sof marjinal rentabelligi|Sof marja Silence Therapeutics Inc.|Sotuvning sof rentabelligi PRQR (proqr.com)|Sof marja Codexis Bio (CDXS)|Sotuvning sof marjinal rentabelligi sangamo.com (SGMO)|Sof marja nautilus.bio NAUT|Kompaniya sotuv marjasi Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Sotuvning sof marjinal rentabelligi|GBIO - Sotuvning sof marjinal rentabelligi|BOLD: Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi XCUR|Sof marja Imunon|Phio Pharmaceuticals - Sof foyda marjasi|Sof marja Mustang Bio, Inc. (MBIO)|Kompaniya sotuv marjasi TransCode Therapeutics, Inc.|Sof marja Bionano Genomics BNGO|Sof foyda normasi APDN|BLUE - Sof marja|Sof foyda marjasi IPA|Omega Therapeutics, Inc. (OMGA) - Sof marja|Singular Genomics Corp (OMIC) - Sotuvning sof marjinal rentabelligi|RGLS (Regulus Therapeutics, Inc.) - Sotuvning sof marjinal rentabelligi|SYRS: Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi TBIO (Telesis Bio Inc.)|Sotuvning sof marjinal rentabelligi TRACON Pharmaceuticals Inc. (TCON)|Sof marja Unity Bio UBX